Complement in the homeostatic and ischemic brain

Frontiers in Immunology

Volumn 6, Issue JUL, 2015, Pages

  Alawieh, Ali ^a   Elvington, Andrew ^b   Tomlinson, Stephen ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Brain ischemia; Complement; Innate immunity; Neuroprotection; Reperfusion injury; Stroke

Indexed keywords

CASPASE 3; CASPASE 9; CD59 ANTIGEN; COBROTOXIN; COMPLEMENT COMPONENT C3B RECEPTOR; DECAY ACCELERATING FACTOR; MANNOSE BINDING LECTIN; MEMBRANE COFACTOR PROTEIN; MESSENGER RNA; MICRORNA; N METHYL DEXTRO ASPARTIC ACID; TISSUE PLASMINOGEN ACTIVATOR; VESICULAR GLUTAMATE TRANSPORTER 1;

APOPTOSIS; BRAIN ISCHEMIA; CELL MIGRATION; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; EPILEPTOGENESIS; GENOTYPE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

EID: 84938518494     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00417     Document Type: Review

References (131)

1. Aivazian, V.A., Boiadzhian, A.S., Manukian, L.A., Avetisian, G.V., and Grigorian, G.S. (2005). [Complement componenets, C3 and factors B, in the blood of patients with acute ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova Suppl 15, 57-60.
2. Akita, N., Nakase, H., Kanemoto, Y., Kaido, T., Nishioka, T., and Sakaki, T. (2001). The effect of C 1 esterase inhibitor on ischemia: reperfusion injury in the rat brain]. No to shinkei= Brain and nerve 53, 641.
3. Alexander, J.J., Anderson, A.J., Barnum, S.R., Stevens, B., and Tenner, A.J. (2008). The complement cascade: Yin-Yang in neuroinflammation-neuro-protection and-degeneration. J Neurochem 107, 1169-1187.
4. Amara, U., Rittirsch, D., Flierl, M., Bruckner, U., Klos, A., Gebhard, F., Lambris, J.D., and Huber-Lang, M. (2008). Interaction between the coagulation and complement system. Adv Exp Med Biol 632, 71-79.
5. Arumugam, T.V., Tang, S.C., Lathia, J.D., Cheng, A., Mughal, M.R., Chigurupati, S., Magnus, T., Chan, S.L., Jo, D.G., Ouyang, X., Fairlie, D.P., Granger, D.N., Vortmeyer, A., Basta, M., and Mattson, M.P. (2007). Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci U S A 104, 14104-14109.
6. Atkinson, C., Song, H., Lu, B., Qiao, F., Burns, T.A., Holers, V.M., Tsokos, G.C., and Tomlinson, S. (2005). Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J Clin Invest 115, 2444-2453.
7. Austen, W.G., Jr., Zhang, M., Chan, R., Friend, D., Hechtman, H.B., Carroll, M.C., and Moore, F.D., Jr. (2004). Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM. Surgery 136, 401-406.
8. Barber, P.A., Davis, S.M., Infeld, B., Baird, A.E., Donnan, G.A., Jolley, D., and Lichtenstein, M. (1998). Spontaneous reperfusion after ischemic stroke is associated with improved outcome. Stroke 29, 2522-2528.
9. Barber, P.A., Zhang, J., Demchuk, A.M., Hill, M.D., and Buchan, A.M. (2001). Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56, 1015-1020.
10. Bednar, M.M., Gross, C.E., Russell, S.R., Short, D., and Giclas, P.C. (1997). Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke. J Neurosurg 86, 139-142.
11. Beek, J., Elward, K., and Gasque, P. (2003). Activation of complement in the central nervous system. Annals of the New York Academy of Sciences 992, 56-71.
12. Bellander, B.M., Singhrao, S.K., Ohlsson, M., Mattsson, P., and Svensson, M. (2001). Complement activation in the human brain after traumatic head injury. J Neurotrauma 18, 1295-1311.
13. Benard, M., Gonzalez, B.J., Schouft, M.T., Falluel-Morel, A., Vaudry, D., Chan, P., Vaudry, H., and Fontaine, M. (2004). Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation. Neuroprotective effect of C5a against apoptotic cell death. J Biol Chem 279, 43487-43496.
14. Benard, M., Raoult, E., Vaudry, D., Leprince, J., Falluel-Morel, A., Gonzalez, B.J., Galas, L., Vaudry, H., and Fontaine, M. (2008). Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum. Mol Immunol 45, 3767-3774.
15. Benoit, M.E., and Tenner, A.J. (2011). Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci 31, 3459-3469.
16. Boos, L., Szalai, A.J., and Barnum, S.R. (2005). C3a expressed in the central nervous system protects against LPS-induced shock. Neurosci Lett 387, 68-71.
17. Busche, M.N., Pavlov, V., Takahashi, K., and Stahl, G.L. (2009). Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin. Am J Physiol Heart Circ Physiol 297, H1853-1859.
18. Carmichael, S.T. (2003). Plasticity of cortical projections after stroke. Neuroscientist 9, 64-75.
19. Carmichael, S.T., Archibeque, I., Luke, L., Nolan, T., Momiy, J., and Li, S. (2005). Growthassociated gene expression after stroke: evidence for a growth-promoting region in periinfarct cortex. Exp Neurol 193, 291-311.
20. Carmichael, S.T., Wei, L., Rovainen, C.M., and Woolsey, T.A. (2001). New patterns of intracortical projections after focal cortical stroke. Neurobiol Dis 8, 910-922.
21. Cavusoglu, E., Eng, C., Chopra, V., Ruwende, C., Yanamadala, S., Clark, L.T., Pinsky, D.J., and Marmur, J.D. (2007). Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography. Amer J Cardiol. 100, 164-168.
22. Cervera, A., Planas, A.M., Justicia, C., Urra, X., Jensenius, J.C., Torres, F., Lozano, F., and Chamorro, A. (2010). Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PLoS One 5, e8433.
23. Chu, Y., Jin, X., Parada, I., Pesic, A., Stevens, B., Barres, B., and Prince, D.A. (2010). Enhanced synaptic connectivity and epilepsy in C1q knockout mice. Proc Nat Acad Sci, 107, 7975-7980.
24. Cojocaru, I.M., Cojocaru, M., Tanasescu, R., Burcin, C., Atanasiu, A.N., Petrescu, A.M., Mitu, A.C., Iliescu, I., and Dumitrescu, L. (2008). Changes in plasma levels of complement in patients with acute ischemic stroke. Rom J Intern Med 46, 77-80.
25. Costa, Cristina, et al. Role of complement component C5 in cerebral ischemia/reperfusion injury. (2006). Brain Res, 1100, 142-151.
26. Cowell, R.M., Plane, J.M., and Silverstein, F.S. (2003). Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats. J Neurosci 23, 9459-9468.
27. Crane, J.W., Baiquni, G.P., Sullivan, R.K., Lee, J.D., Sah, P., Taylor, S.M., Noakes, P.G., and Woodruff, T.M. (2009). The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres. J Neuroinflam, 6, 34.
28. Cudrici, C., Niculescu, F., Jensen, T., Zafranskaia, E., Fosbrink, M., Rus, V., Shin, M.L., and Rus, H. (2006). C5b-9 terminal complex protects oligodendrocytes from apoptotic cell death by inhibiting caspase-8 processing and up-regulating FLIP. J Immunol 176, 3173-3180.
29. Davoust, N., Jones, J., Stahel, P.F., Ames, R.S., and Barnum, S.R. (1999). Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia 26, 201-211.
30. De La Rosa, X., Cervera, A., Kristoffersen, A.K., Valdes, C.P., Varma, H.M., Justicia, C., Durduran, T., Chamorro, A., and Planas, A.M. (2014). Mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice. Stroke 45, 1453-1459.
31. De Simoni, M.G., Rossi, E., Storini, C., Pizzimenti, S., Echart, C., and Bergamaschini, L. (2004). The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q. Amer J Pathol, 164, 1857-1863.
32. De Simoni, M.G., Storini, C., Barba, M., Catapano, L., Arabia, A.M., Rossi, E., and Bergamaschini, L. (2003). Neuroprotection by complement (C1) inhibitor in mouse transient brain ischemia. J Cereb Blood Flow Metab 23, 232-239.
33. Di Napoli, M. (2001). Systemic complement activation in ischemic stroke. Stroke 32, 1443-1448.
34. Ducruet, A.F., Hassid, B.G., Mack, W.J., Sosunov, S.A., Otten, M.L., Fusco, D.J., Hickman, Z.L., Kim, G.H., Komotar, R.J., and Mocco, J. (2008). C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent. J Cereb Blood Flow Metab 28, 1048-1058.
35. Ducruet, A.F., Mocco, J., Mack, W.J., Coon, A.L., Marsh, H.C., Pinsky, D.J., Hickman, Z.L., Kim, G.H., and Connolly, E.S., Jr. (2007). Pre-clinical evaluation of an sLe xglycosylated complement inhibitory protein in a non-human primate model of reperfused stroke. J Med Primatol 36, 375-380.
36. Ducruet, A.F., Sosunov, S.A., Zacharia, B.E., Gorski, J., Yeh, M.L., Derosa, P., Cohen, G., Gigante, P.R., and Connolly, E.S., Jr. (2011). The Neuroprotective Effect of Genetic Mannose-binding Lectin Deficiency is not Sustained in the Sub-acute Phase of Stroke. Transl Stroke Res 2, 588-599.
37. Ducruet, A.F., Zacharia, B.E., Sosunov, S.A., Gigante, P.R., Yeh, M.L., Gorski, J.W., Otten, M.L., Hwang, R.Y., Derosa, P.A., Hickman, Z.L., Sergot, P., and Connolly, E.S., Jr. (2012). Complement inhibition promotes endogenous neurogenesis and sustained antiinflammatory neuroprotection following reperfused stroke. PLoS One 7, e38664.
38. Elvington, A., Atkinson, C., Kulik, L., Zhu, H., Yu, J., Kindy, M.S., Holers, V.M., and Tomlinson, S. (2012a). Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice. J Immunol 188, 1460-1468.
39. Elvington, A., Atkinson, C., Zhu, H., Yu, J., Takahashi, K., Stahl, G.L., Kindy, M.S., and Tomlinson, S. (2012b). The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J Immunol 189, 4640-4647.
40. Engstrom, G., Hedblad, B., Janzon, L., and Lindgarde, F. (2007). Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study. Eur J Cardiovasc Prev Rehabil 14, 392-397.
41. Figueroa, E., Gordon, L.E., Feldhoff, P.W., and Lassiter, H.A. (2005). The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats. Neurosci Lett 380, 48-53.
42. Fisher, M., Feuerstein, G., Howells, D.W., Hurn, P.D., Kent, T.A., Savitz, S.I., and Lo, E.H. (2009). Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40, 2244-2250.
43. Frauenknecht, V., Thiel, S., Storm, L., Meier, N., Arnold, M., Schmid, J.P., Saner, H., and Schroeder, V. (2013). Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio-and cerebrovascular diseases. Clin Exp Immunol 173, 112-120.
44. Garrett, M.C., Otten, M.L., Starke, R.M., Komotar, R.J., Magotti, P., Lambris, J.D., Rynkowski, M.A., and Connolly, E.S. (2009). Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage. Brain Res 1298, 171-177.
45. Gasque, P., Dean, Y., Mcgreal, E., Vanbeek, J., and Morgan, B. (2000). Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology 49, 171-186.
46. Gasque, P., Fontaine, M., and Morgan, B.P. (1995). Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J Immunol, 154, 4726-4733.
47. Gesuete, R., Storini, C., Fantin, A., Stravalaci, M., Zanier, E.R., Orsini, F., Vietsch, H., Mannesse, M.L., Ziere, B., Gobbi, M., and De Simoni, M.G. (2009). Recombinant C1 inhibitor in brain ischemic injury. Ann Neurol 66, 332-342.
48. Gill, R., Kemp, J.A., Sabin, C., and Pepys, M.B. (2004). Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats. J Cereb Blood Flow Metab 24, 1214-1218.
49. Harboe, M., Ulvund, G., Vien, L., Fung, M., and Mollnes, T.E. (2004). The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol 138, 439-446.
50. Harhausen, D., Khojasteh, U., Stahel, P.F., Morgan, B.P., Nietfeld, W., Dirnagl, U., and Trendelenburg, G. (2010). Membrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice. J Neuroinflam 7, 15.
51. Heese, K., Hock, C., and Otten, U. (1998). Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 70, 699-707.
52. Heimann, A., Takeshima, T., Horstick, G., and Kempski, O. (1999). C1-esterase inhibitor reduces infarct volume after cortical vein occlusion. Brain Res 838, 210-213.
53. Hoke, M., Speidl, W., Schillinger, M., Minar, E., Zehetmayer, S., Schonherr, M., Wagner, O., and Mannhalter, C. (2012). Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis. Eur J Clin Invest 42, 921-926.
54. Holers, V.M., and Thurman, J.M. (2004). The alternative pathway of complement in disease: opportunities for therapeutic targeting. Mol Immunol 41, 147-152.
55. Huang, J., Kim, L.J., Mealey, R., Marsh, H.C., Jr., Zhang, Y., Tenner, A.J., Connolly, E.S., Jr., and Pinsky, D.J. (1999). Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285, 595-599.
56. Huber-Lang, M., Sarma, J.V., Zetoune, F.S., Rittirsch, D., Neff, T.A., Mcguire, S.R., Lambris, J.D., Warner, R.L., Flierl, M.A., Hoesel, L.M., Gebhard, F., Younger, J.G., Drouin, S.M., Wetsel, R.A., and Ward, P.A. (2006). Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 12, 682-687.
57. Hurtado, O., Serrano, J., Sobrado, M., Fernández, A., Lizasoain, I., Martínez-Murillo, R., Moro, M., and Martínez, A. (2010). Lack of adrenomedullin, but not complement factor H, results in larger infarct size and more extensive brain damage in a focal ischemia model. Neuroscience 171, 885-892.
58. Iadecola, C., and Anrather, J. (2011). The immunology of stroke: from mechanisms to translation. Nat Med 17, 796-808.
59. Imm, M.D., Feldhoff, P.W., Feldhoff, R.C., and Lassiter, H.A. (2002). The administration of complement component C9 augments post-ischemic cerebral infarction volume in neonatal rats. Neurosci Lett 325, 175-178.
60. Jauneau, A.C., Ischenko, A., Chatagner, A., Benard, M., Chan, P., Schouft, M.T., Patte, C., Vaudry, H., and Fontaine, M. (2006). Interleukin-1beta and anaphylatoxins exert a synergistic effect on NGF expression by astrocytes. J Neuroinflam 3, 8.
61. Katzan, I.L., Hammer, M.D., Hixson, E.D., Furlan, A.J., Abou-Chebl, A., Nadzam, D.M., and Cleveland Clinic Health System Stroke Quality Improvement, T. (2004). Utilization of intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 61, 346-350.
62. Kim, G.H., Mocco, J., Hahn, D.K., Kellner, C.P., Komotar, R.J., Ducruet, A.F., Mack, W.J., and Connolly, E.S., Jr. (2008). Protective effect of C5a receptor inhibition after murine reperfused stroke. Neurosurgery 63, 122-125; discussion 125-126.
63. Kramer, J., Harcos, P., Prohaszka, Z., Horvath, L., Karadi, I., Singh, M., Csaszar, A., Romics, L., and Fust, G. (2000). Frequencies of certain complement protein alleles and serum levels of anti-heat-shock protein antibodies in cerebrovascular diseases. Stroke 31, 2648-2652.
64. Kulik, L., Fleming, S.D., Moratz, C., Reuter, J.W., Novikov, A., Chen, K., Andrews, K.A., Markaryan, A., Quigg, R.J., Silverman, G.J., Tsokos, G.C., and Holers, V.M. (2009). Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J Immunol 182, 5363-5373.
65. Levi-Strauss, M., and Mallat, M. (1987). Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J Immunol, 139, 2361-2366.
66. Lew, S.M., Gross, C.E., Bednar, M.M., Russell, S.J., Fuller, S.P., Ellenberger, C.L., and Howard, D. (1999). Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke. Brain Res Bull 48, 325-331.
67. Li, G., Fan, R.M., Chen, J.L., Wang, C.M., Zeng, Y.C., Han, C., Jiao, S., Xia, X.P., Chen, W., and Yao, S.T. (2013). Neuroprotective effects of Argatroban and C5a receptor antagonist (PMX53) following intracerebral hemorrhage. Clin Exp Immunol 175, 285-295.
68. Li, S., Xian, J., He, L., Luo, X., Tan, B., Yang, Y., Liu, G., and Wang, Z. (2011). The protective effect of SCR(15-18) on cerebral ischemia-reperfusion injury. Neurol Res 33, 866-874.
69. Lindsberg, P.J., Ohman, J., Lehto, T., Karjalainen-Lindsberg, M.L., Paetau, A., Wuorimaa, T., Carpen, O., Kaste, M., and Meri, S. (1996). Complement activation in the central nervous system following blood-brain barrier damage in man. Ann Neurol 40, 587-596
70. Luo, H., Li, W., Yang, F., Zhou, L., Wen, P., and Zhou, J. (2013). Expressions of complement C1q and C3c in rat brain tissues with cerebral ischemia/reperfusion injury. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 29, 897-900.
71. Mack, W.J., Sughrue, M.E., Ducruet, A.F., Mocco, J., Sosunov, S.A., Hassid, B.G., Silverberg, J.Z., Ten, V.S., Pinsky, D.J., and Connolly, E.S., Jr. (2006). Temporal pattern of C1q deposition after transient focal cerebral ischemia. J Neurosci Res 83, 883-889.
72. Mcmullen, M.E., Hart, M.L., Walsh, M.C., Buras, J., Takahashi, K., and Stahl, G.L. (2006). Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology 211, 759-766.
73. Mead, R.J., Singhrao, S.K., Neal, J.W., Lassmann, H., and Morgan, B.P. (2002). The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. J Immunol 168, 458-465.
74. Mehta, N., Uchino, K., Fakhran, S., Sattar, M.A., Branstetter, B.F.T., Au, K., Navratil, J.S., Paul, B., Lee, M., Gallagher, K.M., Manzi, S., Ahearn, J.M., and Kao, A.H. (2008). Platelet C4d is associated with acute ischemic stroke and stroke severity. Stroke 39, 3236-3241.
75. Mocco, J., Mack, W.J., Ducruet, A.F., King, R.G., Sughrue, M.E., Coon, A.L., Sosunov, S.A., Sciacca, R.R., Zhang, Y., Marsh, H.C., Jr., Pinsky, D.J., and Connolly, E.S., Jr. (2006a). Preclinical evaluation of the neuroprotective effect of soluble complement receptor type 1 in a nonhuman primate model of reperfused stroke. J Neurosurg 105, 595-601.
76. Mocco, J., Mack, W.J., Ducruet, A.F., Sosunov, S.A., Sughrue, M.E., Hassid, B.G., Nair, M.N., Laufer, I., Komotar, R.J., Claire, M., Holland, H., Pinsky, D.J., and Connolly, E.S., Jr. (2006b). Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res 99, 209-217.
77. Mocco, J., Wilson, D.A., Komotar, R.J., Sughrue, M.E., Coates, K., Sacco, R.L., Elkind, M.S., and Connolly, E.S., Jr. (2006c). Alterations in plasma complement levels after human ischemic stroke. Neurosurgery 59, 28-33.
78. Moriyama, M., Fukuhara, T., Britschgi, M., He, Y., Narasimhan, R., Villeda, S., Molina, H., Huber, B.T., Holers, M., and Wyss-Coray, T. (2011). Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis. J Neurosci 31, 3981-3989.
79. Morrison, H., Frye, J., Davis-Gorman, G., Funk, J., Mcdonagh, P., Stahl, G., and Ritter, L. (2011). The contribution of mannose binding lectin to reperfusion injury after ischemic stroke. Curr Neurovasc Res 8, 52-63.
80. Mukherjee, P., and Pasinetti, G.M. (2001). Complement anaphylatoxin C5a neuroprotects through mitogen-activated protein kinase-dependent inhibition of caspase 3. J Neurochem 77, 43-49.
81. Mukherjee, P., Thomas, S., and Pasinetti, G.M. (2008). Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo. J Neuroinflam, 5, 5.
82. Murphy, T.H., and Corbett, D. (2009). Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci 10, 861-872.
83. Olsson, S., Stokowska, A., Holmegaard, L., Jood, K., Blomstrand, C., Pekna, M., and Jern, C. (2011). Genetic variation in complement component C3 shows association with ischaemic stroke. Eur J Neurol, 18, 1272-1274.
84. Orsini, F., Villa, P., Parrella, S., Zangari, R., Zanier, E.R., Gesuete, R., Stravalaci, M., Fumagalli, S., Ottria, R., Reina, J.J., Paladini, A., Micotti, E., Ribeiro-Viana, R., Rojo, J., Pavlov, V.I., Stahl, G.L., Bernardi, A., Gobbi, M., and De Simoni, M.G. (2012). Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia. Circulation 126, 1484-1494.
85. Osaka, H., Mukherjee, P., Aisen, P.S., and Pasinetti, G.M. (1999). Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. J Cell Biochem 73, 303-311.
86. Osthoff, M., Katan, M., Fluri, F., Schuetz, P., Bingisser, R., Kappos, L., Steck, A.J., Engelter, S.T., Mueller, B., and Christ-Crain, M. (2011). Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients. PloS one 6, e21338.
87. Patel, R.D., and Saver, J.L. (2013). Evolution of reperfusion therapies for acute brain and acute myocardial ischemia: a systematic, comparative analysis. Stroke 44, 94-98.
88. Pavlovski, D., Thundyil, J., Monk, P.N., Wetsel, R.A., Taylor, S.M., and Woodruff, T.M. (2012). Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis. Faseb j 26, 3680-3690.
89. Pedersen, E.D., Froyland, E., Kvissel, A.K., Pharo, A.M., Skalhegg, B.S., Rootwelt, T., and Mollnes, T.E. (2007). Expression of complement regulators and receptors on human NT2-N neurons-effect of hypoxia and reoxygenation. Mol Immunol 44, 2459-2468.
90. Pedersen, E.D., Loberg, E.M., Vege, E., Daha, M.R., Maehlen, J., and Mollnes, T.E. (2009). In situ deposition of complement in human acute brain ischaemia. Scand J Immunol 69, 555-562.
91. Pedersen, E.D., Waje-Andreassen, U., Vedeler, C.A., Aamodt, G., and Mollnes, T.E. (2004). Systemic complement activation following human acute ischaemic stroke. Clin Exp Immunol 137, 117-122.
92. Persson, M., Pekna, M., Hansson, E., and Ronnback, L. (2009). The complement-derived anaphylatoxin C5a increases microglial GLT-1 expression and glutamate uptake in a TNF-alpha-independent manner. Eur J Neurosci 29, 267-274.
93. Pisalyaput, K., and Tenner, A.J. (2008). Complement component C1q inhibits beta-amyloid-and serum amyloid P-induced neurotoxicity via caspase-and calpain-independent mechanisms. J Neurochem 104, 696-707.
94. Rahpeymai, Y., Hietala, M.A., Wilhelmsson, U., Fotheringham, A., Davies, I., Nilsson, A.K., Zwirner, J., Wetsel, R.A., Gerard, C., Pekny, M., and Pekna, M. (2006). Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J 25, 1364-1374.
95. Ramaglia, V., Daha, M., and Baas, F. (2008). The complement system in the peripheral nerve: Friend or foe? Mol Immunol, 45, 3865-3877.
96. Ricklin, D., Hajishengallis, G., Yang, K., and Lambris, J.D. (2010). Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11, 785-797.
97. Rogers, J., Strohmeyer, R., Kovelowski, C.J., and Li, R. (2002). Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40, 260-269.
98. Rupprecht, T.A., Angele, B., Klein, M., Heesemann, J., Pfister, H.W., Botto, M., and Koedel, U. (2007). Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system. J Immunol 178, 1861-1869.
99. Rynkowski, M.A., Kim, G.H., Garrett, M.C., Zacharia, B.E., Otten, M.L., Sosunov, S.A., Komotar, R.J., Hassid, B.G., Ducruet, A.F., and Lambris, J.D. (2008). C3a receptor antagonist attenuates brain injury after intracerebral hemorrhage. J Cereb Blood Flow Metab, 29, 98-107.
100. Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R., Greenberg, M., Barres, B. and Stevens, B. (2012). Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74, 691-705.
101. Schafer, M.K., Schwaeble, W.J., Post, C., Salvati, P., Calabresi, M., Sim, R.B., Petry, F., Loos, M., and Weihe, E. (2000). Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia. J Immunol 164, 5446-5452.
102. Schultz, S.J., Aly, H., Hasanen, B.M., Khashaba, M.T., Lear, S.C., Bendon, R.W., Gordon, L.E., Feldhoff, P.W., and Lassiter, H.A. (2005). Complement component 9 activation, consumption, and neuronal deposition in the post-hypoxic-ischemic central nervous system of human newborn infants. Neurosci Lett 378, 1-6.
103. Shinjyo, N., Stahlberg, A., Dragunow, M., Pekny, M., and Pekna, M. (2009). Complementderived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells. Stem Cells 27, 2824-2832.
104. Soane, L., Rus, H., Niculescu, F., and Shin, M.L. (1999). Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation. J Immunol 163, 6132-6138.
105. Somani, R., Grant, P.J., Kain, K., Catto, A.J., and Carter, A.M. (2006). Complement C3 and Creactive protein are elevated in South Asians independent of a family history of stroke. Stroke 37, 2001-2006.
106. Speidl, W.S., Exner, M., Amighi, J., Kastl, S.P., Zorn, G., Maurer, G., Wagner, O., Huber, K., Minar, E., Wojta, J., and Schillinger, M. (2005). Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur Heart J 26, 2294-2299.
107. Stahel, P.F., and Bamum, S.R. (1997). Bacterial meningitis: complement gene expression in the central nervous system. Immunopharmacology 38, 65-72.
108. Stephan, A.H., Barres, B.A., and Stevens, B. (2012). The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci 35, 369-389.
109. Stevens, B., Allen, N.J., Vazquez, L.E., Howell, G.R., Christopherson, K.S., Nouri, N., Micheva, K.D., Mehalow, A.K., Huberman, A.D., and Stafford, B. (2007). The classical complement cascade mediates CNS synapse elimination. Cell 131, 1164-1178.
110. Stokowska, A., Olsson, S., Holmegaard, L., Jood, K., Blomstrand, C., Jern, C., and Pekna, M. (2011). Plasma C3 and C3a levels in cryptogenic and large-vessel disease stroke: associations with outcome. Cerebrovasc Dis 32, 114-122.
111. Stokowska, A., Olsson, S., Holmegaard, L., Jood, K., Blomstrand, C., Jern, C., and Pekna, M. (2013). Cardioembolic and Small Vessel Disease Stroke Show Differences in Associations between Systemic C3 Levels and Outcome. PLoS One 8, e72133.
112. Storini, C., Rossi, E., Marrella, V., Distaso, M., Veerhuis, R., Vergani, C., Bergamaschini, L., and De Simoni, M.G. (2005). C1-inhibitor protects against brain ischemia-reperfusion injury via inhibition of cell recruitment and inflammation. Neurobiol Dis 19, 10-17.
113. Ten, V.S., Sosunov, S.A., Mazer, S.P., Stark, R.I., Caspersen, C., Sughrue, M.E., Botto, M., Connolly, E.S., Jr., and Pinsky, D.J. (2005). C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice. Stroke 36, 2244-2250.
114. Széplaki, G., Szegedi, R., Hirschberg, K., Gombos, T., Varga, L., Karádi, I., Entz, L., Széplaki, Z., Garred, P., and Prohászka, Z. (2009). Strong complement activation after acute ischemic stroke is associated with unfavorable outcomes. Atherosclerosis 204, 315-320.
115. Ten, V.S., Yao, J., Ratner, V., Sosunov, S., Fraser, D.A., Botto, M., Sivasankar, B., Morgan, B.P., Silverstein, S., Stark, R., Polin, R., Vannucci, S.J., Pinsky, D., and Starkov, A.A. (2010). Complement component c1q mediates mitochondria-driven oxidative stress in neonatal hypoxic-ischemic brain injury. J Neurosci 30, 2077-2087.
116. Thundyil, J., Pavlovski, D., Hsieh, Y.H., Gelderblom, M., Magnus, T., Fairlie, D.P., and Arumugam, T.V. (2012). C5a receptor (CD88) inhibition improves hypothermia-induced neuroprotection in an in vitro ischemic model. Neuromolecular Med 14, 30-39.
117. Thurman, J.M., and Holers, V.M. (2006). The central role of the alternative complement pathway in human disease. J Immunol 176, 1305-1310.
118. Tohgi, H., Utsugisawa, K., and Nagane, Y. (2000). Hypoxia-induced expression of C1q, a subcomponent of the complement system, in cultured rat PC12 cells. Neurosci Lett 291, 151-154.
119. Van Beek, J., Nicole, O., Ali, C., Ischenko, A., Mackenzie, E.T., Buisson, A., and Fontaine, M. (2001). Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport 12, 289-293.
120. Vasthare, U.S., Barone, F.C., Sarau, H.M., Rosenwasser, R.H., Dimartino, M., Young, W.F., and Tuma, R.F. (1998). Complement depletion improves neurological function in cerebral ischemia. Brain Res Bull 45, 413-419.
121. Wieloch, T., and Nikolich, K. (2006a). Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 16, 258-264.
122. Wieloch, T., and Nikolich, K. (2006b). Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 16, 258-264.
123. Williams, J.P., Pechet, T.T., Weiser, M.R., Reid, R., Kobzik, L., Moore, F.D., Jr., Carroll, M.C., and Hechtman, H.B. (1999). Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) 86, 938-942.
124. Yang, J., Ahn, H.N., Chang, M., Narasimhan, P., Chan, P.H., and Song, Y.S. (2013). Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice. J Neurochem,124, 523-535.
125. Zee, R.Y., Diehl, K.A., and Ridker, P.M. (2006). Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study. Atherosclerosis 187, 332-335.
126. Zhang, B., Yang, N., and Gao, C. (2014a). Is plasma C3 and C4 levels useful in young cerebral ischemic stroke patients? Associations with prognosis at 3 months. J Thromb, 39, 209-214.
127. Zhang, M., Alicot, E.M., Chiu, I., Li, J., Verna, N., Vorup-Jensen, T., Kessler, B., Shimaoka, M., Chan, R., Friend, D., Mahmood, U., Weissleder, R., Moore, F.D., and Carroll, M.C. (2006a). Identification of the target self-antigens in reperfusion injury. J Exp Med 203, 141-152.
128. Zhang, M., Austen, W.G., Jr., Chiu, I., Alicot, E.M., Hung, R., Ma, M., Verna, N., Xu, M., Hechtman, H.B., Moore, F.D., Jr., and Carroll, M.C. (2004). Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A 101, 3886-3891.
129. Zhang, M., Takahashi, K., Alicot, E.M., Vorup-Jensen, T., Kessler, B., Thiel, S., Jensenius, J.C., Ezekowitz, R.A., Moore, F.D., and Carroll, M.C. (2006b). Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol 177, 4727-4734.
130. Zhang, Z.G., Wang, C., Wang, J., Zhang, Z., Yang, Y.L., Gao, L., Zhang, X.Y., Chang, T., Gao, G.D., and Li, L.H. (2014b). Prognostic Value of Mannose-Binding Lectin: 90-Day Outcome in Patients with Acute Ischemic Stroke. Mol Neurobiol 51, 230-239.
131. Zipfel, P.F., and Skerka, C. (2009). Complement regulators and inhibitory proteins. Nat Rev Immunol 9, 729-740.